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Abstract: Background: 
Health anxiety is common in medical settings and can be treated successfully by cognitive behaviour 
therapy (CBT).  However it is not clear who might be best placed to deliver this therapy.   
Objectives: 
In a planned secondary analysis of data from a randomised trial of adapted cognitive behaviour 
therapy for health anxiety we compared outcomes of therapy delivered by nurses and other 
professional groups.  
 
Design: 
A randomised controlled trial with two treatment arms, 5-10 sessions of cognitive behaviour therapy 
adapted health anxiety (CBT-HA) or standard care. The study is registered as ISRCTN14565822. 
Setting:  Cardiology, endocrine, gastroenterology, neurological and respiratory clinics in six general 
hospitals in the UK covering urban, suburban and rural areas. 
 
Participants: Medical patients attending the clinics who had pathological health anxiety and also scored 
for a diagnosis of hypochondriasis. 
 
Methods: 
Patients were randomised to one of two treatment arms, 5-10 sessions of cognitive behaviour therapy 
adapted health anxiety (CBT-HA) or standard care delivered by naive therapists (not randomised) who 
were trained in advance before delivering the treatment. Independent assessment of outcomes by 
researchers masked to allocation status at 3m, 6m, 12m and 24m. 
 
Results:  444 patients were randomised in the trial, 219 to CBT-HA and 225 to  standard care. 373 
(84% ) completed assessments after two years. Those treated by nurses (n = 66) had improvement in 
health anxiety, generalised anxiety and depression outcomes that were significantly better and twice 
as great as those of the professional groups of assistant psychologists (n = 87) and graduate workers (n 
=66)(p<0.01 over all time points).  The number needed to treat (NNT) to show superiority of nurse-
delivered treatment over other treatment delivery was 4 at 6 months and 6 at one year.     
 
 
Conclusion:  General nurses, after suitable training, are very effective therapists for patients with 
health anxiety in medical clinics and should be the therapists of choice for patients in these settings.   
 
 
The study is registered as ISRCTN14565822. 
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 'What is already known about the topic?’  
 Nurses have often been employed as therapists for psychological treatments but are 
not generally regarded as competent as psychologists 
 Health anxiety (formally called hypochondriasis) is very common in hospital clinics 
where psychologists are not often present to give therapy 
 Cognitive therapy for health anxiety is effective when given by trained psychologists    
 
'What this paper adds'  
 In this large randomised trial in medical out-patient clinics two general nurses with 
no psychological experience, after preliminary training and supervision, were 
significantly superior to psychologists and other therapists in reducing health anxiety 
and related mood symptoms both after 3 and 6 months and after 2 years 
 The findings suggest that nurses in medical clinics would be ideally suited to provide 
cognitive behaviour therapy for health anxiety in hospital settings 
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Therapist differences in a randomised trial of the outcome of cognitive behaviour therapy 
for health anxiety in medical patients  
 
 
Abstract 
Background: 
Health anxiety is common in medical settings and can be treated successfully by cognitive 
behaviour therapy (CBT).  However it is not clear who might be best placed to deliver this 
therapy.   
Objectives: 
In a planned secondary analysis of data from a randomised trial of adapted cognitive 
behaviour therapy for health anxiety we compared outcomes of therapy delivered by nurses 
and other professional groups.  
 
Design: 
A randomised controlled trial with two treatment arms, 5-10 sessions of cognitive behaviour 
therapy adapted health anxiety (CBT-HA) or standard care. The study is registered as 
ISRCTN14565822. 
Setting:  Cardiology, endocrine, gastroenterology, neurological and respiratory clinics in six 
general hospitals in the UK covering urban, suburban and rural areas. 
 
Participants: Medical patients attending the clinics who had pathological health anxiety and 
also scored for a diagnosis of hypochondriasis. 
 
Methods: 
Patients were randomised to one of two treatment arms, 5-10 sessions of cognitive 
behaviour therapy adapted health anxiety (CBT-HA) or standard care delivered by naive 
therapists (not randomised) who were trained in advance before delivering the treatment. 
*Manuscript (without Author Details)
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Independent assessment of outcomes by researchers masked to allocation status at 3m, 6m, 
12m and 24m. 
 
Results:  444 patients were randomised in the trial, 219 to CBT-HA and 225 to  standard 
care. 373 (84% ) completed assessments after two years. Those treated by nurses (n = 66) 
had improvement in health anxiety, generalised anxiety and depression outcomes that were 
significantly better and twice as great as those of the professional groups of assistant 
psychologists (n = 87) and graduate workers (n =66)(p<0.01 over all time points).  The 
number needed to treat (NNT) to show superiority of nurse-delivered treatment over other 
treatment delivery was 4 at 6 months and 6 at one year.     
 
 
Conclusion:  General nurses, after suitable training, are very effective therapists for patients 
with health anxiety in medical clinics and should be the therapists of choice for patients in 
these settings.   
 
 
The study is registered as ISRCTN14565822. 
 
 
Introduction 
Health anxiety is a relatively new diagnosis in psychiatry that has partly replaced the 
previous one of hypochondriasis, now abandoned in the latest US classification, DSM-51-2. 
Because of this change there are limited data on its prevalence but it does appear to be a 
common condition  in the community (3.5%) 3 and in secondary medical care (20%)4 . These 
figures for health anxiety are much greater than those for hypochondriasis, which is a 
confusing diagnosis of limited acceptability5-6. Health anxiety leads to unnecessary use of 
health services7 because of additional medical consultations and investigations.  Following a 
pilot study showing the effectiveness of cognitive behaviour therapy (CBT) delivered by 
expert therapists8 we set up the  CHAMP (Cognitive behaviour therapy for Health Anxiety in 
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Medical Patients) trial to examine the effectiveness and cost-effectiveness of a modified 
cognitive behavioural treatment for health anxiety (CBT-HA) with assessment of outcomes 
over a two-year period.  At the time the study was formulated  we planned to have all 
therapy delivered by nurses working in or close to the clinics concerned, in order to test a 
model that could be used to deliver therapy more widely if it were found to be successful. 
Unfortunately this was not possible (for mainly financial reasons) and so other therapists 
generally naive to the specific form of cognitive therapy to be given, including assistant 
psychologists and other graduate professionals were also included in the staff to deliver the 
therapy in our final protocol9.  
 
This paper is not concerned with the overall effectiveness of the treatment, as this has been  
demonstrated previously; there was greater benefit in the symptomatic improvement of 
health anxiety and generalised anxiety over the two year period10.   This paper examines the 
outcome separated by therapist type, with a particular emphasis on the effectiveness of the 
therapy given by nurses and possible reasons given for this.  
 
Methods 
The CHAMP trial involved two parallel arms with randomization of eligible patients to 5-10 
sessions of CBT-HA or to standard care in the clinics. Assessments of health anxiety, 
generalised anxiety, depression, social function, quality of life and costs were made over a 
two year period after randomization. The primary outcome was change in the score of 
health anxiety using a standard instrument11. Secondary hypotheses were that health 
anxiety at other time points, generalised anxiety and depression, social functioning and 
quality of life measured by standard measures12-14 would differ between CBT-HA and 
standard care and that CBT-HA would be a cost-effective use of resources. 
 
Participants 
  
All patients over a 20 month period attending medical out-patient clinics in cardiology, 
endocrinology, gastroenterology, neurology and respiratory medicine in 6 general hospitals, 
King's Mill Hospital (North Nottinghamshire), St Mary's Hospital (London), Charing Cross 
Hospital (London), Hammersmith Hospital (London), Chelsea and Westminster Hospital 
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(London), and Hillingdon Hospital (Middlesex), were approached by research assistants by 
agreement with the staff concerned and offered the opportunity to complete a form 
described as 'a scale to see how much you worry about your health'.  This scale, the Health 
Anxiety Inventory, was given to 28,990 people but only those who scored 20 or more on the 
scale were further involved.  
 
Randomisation and masking 
Eligible patients in whom consent was provided were allocated in a 1:1 ratio to the two 
arms of the study according to a computer-generated random sequence using block 
randomisation with varying blocksize of four and six. The allocation sequence was not 
available to any member of the research team until databases had been completed and 
locked.  There was no randomisation of therapists as the provision of therapy was 
determined by the personnel available at each treatment site. 
Treatments 
  
CBT-HA arm  
Cognitive therapy adapted for health anxiety (CBT-HA) was given to patients allocated to the 
active treatment group. This was based on the model first described by Salkovskis and 
Warwick15 and, although based on standard cognitive therapy principles, differed in focusing 
especially on the need for reassurance, hypervigilance, and fear of (rather than actual) 
disease that are core to the condition.  The plan outlined at the beginning was to offer 
between 5 and 10 sessions of one hour each but this was allowed to be flexible and booster 
sessions were also permitted after the end of therapy if required. The intention was to start 
treatment within two weeks of allocation and complete most therapy within 3-6 months.  
Standard care 
Patients allocated to standard care had information given about health anxiety in the course 
of baseline assessment but subsequently had no further psychological input. They continued 
to attend relevant practitioners in primary and secondary care as considered necessary.      
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Therapists 
 To reinforce the pragmatic nature of the trial we did not use experts in cognitive behaviour 
therapy to give the treatment as these are seldom available in medical settings except for 
specialised cases. Instead, naive therapists with an interest in administering the modified 
treatment were trained in two workshops carried out by four supervisors headed by PS and 
HT, and in addition each therapist received supervision from a more senior practitioner at 2-
4 week intervals during therapy.  Patients allocated to the CBT arm of the trial were 
allocated to the next available therapist. The type of therapist was not randomised and all 
were recruited from staff available at each site. Of a total of 17 therapists, 10 were 
psychologists in training, 5 were graduate workers (including one dietician), and two were 
nurses.     
Training and Fidelity of Intervention 
Four experts in the treatment trained the therapists at two workshops and also assessed 
treatment fidelity, together with HW. 50% of all treatment sessions were audio recorded. 
Fidelity was tested using the health anxiety modification of the Cognitive Therapy Rating 
Scale (CTRS-HAV)16. Recordings were assessed by the local supervisor and a random sample 
sent to a supervisor at a different site to assess the level of agreement, with further training 
ending only when an agreement level of 0.80 kappa was reached.  
The study was approved by the North Nottingham Ethics Committee (08/H0403/56) prior to 
the start of data collection. 
 
Inclusion and exclusion criteria 
Those who satisfied the criteria for excessive health anxiety above were included if they 
were (i) aged between 16 and 75, (ii) resident in the area, (iii) had sufficient understanding 
of English to read and complete study questionnaires, and (iv) gave written consent for the 
interviews, audio-taping of 50% of treatment sessions, and (v) gave permission to access 
their medical records. The presence of existing medical pathology, provided it was not a 
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new diagnosis requiring further investigation, was not a study exclusion criterion.  Those 
that were felt clinically to have a level of continuing major pathology that was too severe for 
them to take part in the study, including progressive cognitive impairment, terminal 
disorders, and any major comorbid pathology that would interfere with psychological 
treatment, those who were currently being actively investigated for significant pathology 
suspected by the clinician and for whom cognitive behaviour therapy might confuse or 
cause distress, and any currently under psychiatric care were also excluded. 
 
Assessments of health anxiety (HAI),11anxiety and depression (HADS)12 , social functioning 
(SFQ)13 and health-related quality of life (EQ-5D),14 were made at baseline and assessed 
independently by research assistants at 6m, 12m and 2 years. The quality of life measure 
was linked to the economic assessment and neither are being considered here. Health 
anxiety scores (HAI) were additionally recorded at 3 months.  
 
  
Statistical analysis  
The calculation of the sample size for the main study has been described previously9, and 
was powered to assess the superiority of CBT-HA over standard care. The current study was 
an exploratory comparison of the outcomes of the different therapists and no formal 
sample size calculation was performed.  
  
All analyses were based on the intention-to-treat principle.  The primary endpoint was 
analysed using a mixed model with time, treatment group (nurses, graduate workers, 
assistant psychologists, and standard care), and time x treatment interaction as fixed 
effects, baseline measurement as covariate, and patient as random effect. The treatment 
differences between group comparisons, including one between nurses, graduate workers 
and assistant psychologists combined, were calculated at each time point (3m, 6m, 1 year 
and 2 years).  These differences, together with their 95% confidence intervals (CI), were 
derived from the mixed model. Other secondary endpoints were analysed in the same way.  
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Other assessments were analysed in a similar way.  In addition, the percentage of patients 
achieving normal levels of health anxiety (HAI≤10) or significant improvement (HAII≤15) 
were compared using a generalised estimating equation model with visit, treatment, 
interaction between visits and treatment as fixed effect, baseline measurement of HAI as 
covariate, and patient as random effect (an exchangeable covariance structure).  
   
 
 
Results 
[Figure 1 near here] 
445 patients were randomised to the trial and 376 (76%) completed the follow-up after two 
years (Figure 1). One patient was randomised twice in error, both times to standard care; 
only the first of the assessments was used.  Proportions followed up at other time points are 
shown elsewhere10. The 219 patients randomised to CBT-HA were seen by a total of 17 
therapists.  In patients allocated to CBT-HA there was a significantly greater reduction in 
both health anxiety and generalised anxiety symptoms than in the standard care group at all 
times of testing10. The present paper focuses on the differences between therapists in 
accounting for these differences.  
[Tables 1 and 2 near here]  
Of the 219 patients referred to CBT-HA, 66 (30%) were referred to nurses (n=2) for their 
treatment, 66 (30%) to graduate workers (n=5) and 87 (40%) to assistant psychologists 
(n=10). Details of the demographic characteristics of the 17 therapists are shown in Table 1. 
The two nurses differed from the other therapists in having less general knowledge of CBT, 
being paid higher salaries, and seeing more patients than other therapists. The three groups 
were chosen as they shared some common characteristics; nurses (both trained in general 
nursing), assistant psychologists (a relatively homogeneous group of psychologists who had 
some knowledge of CBT in theory and practice), and a more heterogeneous group of 
graduate workers, including a dietician, graduates in psychology or a related discipline who 
may have had teaching in CBT but very little in the way of practice, and a physician (HT) who 
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had much more experience and acted as a back-up in the study in all centres when no other 
therapists were available. Because of the limited availability of funding there were 
important differences in the distribution of therapists by site. Because funding and 
personnel were available for nurses to be employed at one site (Kings Mill Hospital, 
Nottinghamshire) almost all the patients treated there were seen by two nurses (SM and YL-
S). The distribution by site of the three groups also showed great variation (Table 2). 
Outcome by therapist group  
 
15 patients did not respond to the invitation for treatment after randomisation and 6 more 
did not attend initially but did have some form of contact later. Of the numbers who did not 
attend any sessions there were fewest in the nurse group than in the other two (Table 2) 
but this was not significant (χ2 = 3.18, df 1, P=0.07). The mean number of CBT-HA treatment 
sessions was 6 (range 0-22). The overall differences between CBT-HA and standard care  
were highly significant at all assessment points, including 12 months, the primary outcome 
point (difference=2.98,  95% CI, 1.64 to 4.33, p<0.001). These differences were maintained 
in further analyses with site and baseline scores as covariates.  
 
[Figure 2 and Tables 3-6 near here]  
 
 
The primary outcome in the main trial was the change in HAI scores after 1 year. This 
showed a highly significant benefit for CBT-HA in the main trial10 but when the results were 
separated by therapist type it was clear that the largest component of this difference came 
from the nurse-treated therapists, where significant superiority was found over the other 
groups and standard care at all time of testing. The differences at all time points are shown 
in Figure 2 and the statistical findings in Tables 3 and 4.    This superiority was also shown to 
a lesser, but still significant degree for generalised anxiety (HADS-anxiety score)(overall 
p=0.002), depression (HADS-depression score)(P=0.02), and social functioning (SFQ)(p =0.03 
at 6m and p = 0.06 overall)(Table 3).  The number needed to treat (NNT) to show superiority 
of nurses over the other two therapy groups combined was 4 at 3m and 6m and 6 at one 
year.      
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The mean number of treatment sessions for each of the groups was 7.7 in the nurse group, 
5.7 in the assistant psychologist one, and 4.7 in the graduate worker group, and linear 
regression of session numbers showed significantly greater number of sessions in the nurse 
treated group (P<0.001)(Table 5). The proportion of patients in the nurse-treated group who 
improved (a score of 15 or less on the HAI) at one year (the primary outcome point) was 
53.2% compared with the graduate worker group (42.1%), assistant psychologists (25.3%) 
and standard care (21.8%)(p<0.01) and over all time points this superiority was even more 
marked (P<0.0001)(Table 6). Similar findings were shown in the proportions of those who 
recovered (ie, had an HAI score of 10 or less at one year) ranging from 24.2% in nurse-
treated patients to 4% in those treated by assistant psychologists (p<0.01).    
Fidelity of therapists  
Assessments of the fidelity of therapists’ treatment showed that all except one, an assistant 
psychologist,  scored at an adequate competence level or higher, and this was confirmed by 
an independent assessor.  The two nurses scored slightly above the 50th percentile of all 
therapists on the scale (details given in this format as the scale has not yet been validated) 
but five therapists scored higher, two of these were in the graduate group and three in the 
assistant psychologist one.  
 
Cost-effectiveness of nurses 
 
The study had a cost-effectiveness component built into the protocol9 and the results 
overall showed the study was cost-neutral, but the total costs were dwarfed by the very 
large costs of those who had severe medical illnesses associated with their health anxiety 
(Nikita da Cunha, 2014, BSc thesis, Imperial College) and so savings elsewhere were small in 
comparison10. Excess treatment costs are not covered by grants in research supported by 
major research bodies in the UK and have to be provided by NHS Trusts or other bodies. We 
were fortunate in getting some funding from a subvention fund at the Department of Health 
to pay for the nurses and two therapists elsewhere and the other costs were met by NHS 
Trusts in London.  But this funding was very difficult to obtain and most had to be provided 
at the lowest rate possible.  It was therefore impossible to meet the original requirement for 
all, or even the majority, of therapists to be nurses working in the general hospitals. 
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Discussion 
The results of this trial should be seen in the general context of the employment of nurses in 
the delivery of psychological treatments. It has been well demonstrated that naïve nurses, 
including both those who are generally and mental health trained, are competent at 
delivering behavioural and cognitive behaviour therapies in a range of medical settings, 
mostly for depressive symptoms17-22 but this study is the first to suggest superiority of 
nurses over other professional disciplines, including psychologists.  The main limitation of 
the study is that the patients were not randomised to the therapists and so there could be 
confounding factors.  
 
 
The patients seen by the nurses had more treatment sessions and lower drop-out rates, and 
saw more patients than any of the other therapists. They also saw patients at only one site 
in the trial and had the same supervisor (HT) throughout.  These may have accounted for a 
small part of the difference in efficacy, as better outcomes follow increased experience23, 
but there is no reason to believe that patients with health anxiety are fundamentally 
different in North Nottinghamshire than elsewhere in the country. The possibility that 
nurses were better accepted by patients and were seen as more informed was not tested in 
the study but has resonance in explaining the differences. Both the nurses involved in the 
study were experienced mature general nurses, whereas most of the other therapists were 
considerably younger and less experienced. The obvious inference is that the nurses were 
naturally more knowledgeable about medical disorders than other therapists in other 
groups.  It would therefore not be surprising that patients might have more confidence in 
being treated by a nurse, rather than a psychologist or other professionals independent of 
normal medical care.  The lower drop-out rates in the nurse-treated group also supports the 
hypothesis that they were accepted more readily as therapists.   
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The findings of this trial suggest nurses would be more appropriate than assistant 
psychologists in delivering CBT-HA in medical settings.  This conclusion has to be qualified in 
view of the comments above and needs to be replicated, not least as there are now many 
studies showing that psychologists, usually with signiciantly more training than the ones in 
our study, are very effective as therapists for pathological health anxiety24-27  and also in 
development of the treatment by the Internet28-29, where superiority of CBT-HA has been 
shown over stress management approaches29. The importance of the findings lies in the 
development of this treatment.  If staff are to be trained to deliver CBT-HA in medical clinics 
nurses would seem to be a more appropriate choice than the current practice of referring 
patients to psychologists.  This would also confer advantages in helping to destigmatise 
health anxiety by regarding it as a medical rather than psychiatric concomitant of health 
concerns. This form of management could be incorporated into medical clinics and be 
administered by trained staff such as cardiac rehabilitation nurses and other specialist staff 
in other medical clinics who treat repeated attenders, many of whom have existing medical 
pathology but who suffer unduly from persistent and unnecessary worry over their health. 
This change would add to the increasing interest in showing that nurses can take on some of 
the duties of medical staff effectively30.  
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  Assessed for eligibility (n = 5769) 
Excluded (n = 5324) 
 
• Not meeting inclusion criteria (n = 1389) 
• Declined to participate (n = 3935) 
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Figure 1  - Consort diagram – attached separately as not sure if needed 
 
 
 
Figure 2: Mean differences from baseline in Health Anxiety Inventory (HAI) scores 
between the outcomes of 219 patients with health anxiety treated by nurses (n=66), 
graduate workers (n=66) and assistant psychologists (n=87) at four time points in the 
CHAMP trial  
 
 
 
See Table 3 for details of statistical differences 
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Table 1. Differences in experience and knowledge of CBT by therapist type 
 
 
 
Group for analysis 
of data 
Years of 
professional 
experience  
Previous 
training in 
CBT  
Previous 
experience in 
delivering CBT   
Total 
patients 
referred 
Total 
patients 
not seen 
(%)  
Nurses (n=2)(Band 
6) 
>25 0% 0% 66 3 (4.5) 
Graduates (n = 5) 5-26 40% 20% 66 10 (15) 
Assistant 
psychologists 
(n=10)  
<10 100% 50% 87 8 (10.3) 
 
 
Table 2. Distribution of therapist discipline in the cognitive therapy (CBT-HA) group by 
hospital site 
 
Site Nurses Graduates  Assistant 
psychologists  
Total 
referred 
Total seen 
Kings Mill 
Hospital, 
Nottinghamshire 
66 4 0 70 66 
Charing Cross 
Hospital and 
Hammersmith 
Hospitals, 
London 
0 27 4 31 28 
St Mary’s 
Hospital, London  
0 6 30 36 28 
Chelsea & 
Westminster 
Hospital, London 
0 25 1 26 23 
Hillingdon 
Hospital, 
Middlesex 
0 4 52 56 53 
Totals 66 66 87 219 198 
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Table 3 : Comparison of health anxiety outcome using the Health Anxiety Inventory (HAI)  
separated by therapist group in 444 randomised patients    
 
  N, 
mean(SD)    
Difference 
between 
nurses and 
other groups 
Mean (95% 
CI), p-value 
  
 
 
Visit 
Standard 
care 
CBT by 
Assistant 
psycholog
ists 
CBT by 
Graduates 
CBT by 
Nurses All 
Mean 
scores on 
Health 
Anxiety 
Inventory 
(HAI) 
Baseline  225,  
25.12(4.52) 
87,  
24.76(3.91) 
66   
24.38(4.15) 
66,    
25.53(4.67) 
225   
 25.12(4.52) 
 
3 
Months 
212   
22.37(6.71) 
82   
21.65(6.62) 
59 
21.33(6.97) 
64 
18.15(9.07) 
212 
22.37(6.71) 
4.10 (6.1-3.1) 
P<0.0001 
6 
Months 
204  
22.62(6.81) 
78  
20.13(7.26) 
56 
17.77(8.42) 
63 
14.67(7.53) 
204 
22.62(6.81) 
4.93 (7.0-2.9) 
P<0.0001 
12 
Months 
193  
21.54(7.45) 
75 
19.80(6.96) 
57 
18.53(8.31) 
62 
16.81(8.31) 
193 
21.54(7.45) 
3.24 (5.3-1.2) 
P<0.002 
 
24 
Months 
183  
21.35(7.67) 
76 
19.51(7.22) 
53 
18.98(8.14) 
61 
17.95(8.63) 
183 
21.35(7.67) 
2.49 (4.5-0.5) 
P<0.02 
 All 
periods 
     3.7 (5.4-2.0) 
P<0.0001 
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29 
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31 
32 
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Table 4  : Comparison of generalised anxiety and depression (HADS), and social 
functioning  outcomes (SFQ) separated by therapist group in 444 randomised patients    
 
 
 
 
N 
Mean(SD)    
Difference 
between nurses 
and other groups 
Mean (95% CI), p-
value 
Measure  
Visit 
Standard 
care 
CBT by 
Assistant 
psychologist
s 
CBT by 
Graduates 
CBT by 
Nurses All 
Hospital 
Anxiety and 
Depression 
Scale -HADS 
Anxiety 
Baseline 225 
12.25(3.88) 
87 
12.45(3.77) 
66 
12.62(3.57) 
66 
12.65(3.91) 
444 
12.41(3.81) 
 
6 months 204 
10.96(4.16) 
78 
10.63(4.37) 
56 
9.96(4.99) 
63 
8.51(4.61) 
401 
10.37(4.47) 
1.90 (3.1-0.7) 
P<0.002  
12 
months 
192 
10.57(4.33) 
75 
10.37(4.04) 
57 
9.84(5.01) 
62,9 
06(4.38) 
386 
10.18(4.41) 
1.28 (2.5-0.1) 
P=0.035 
24 
months 
181 
10.13(4.74) 
75 
9.27(4.13) 
53 
10.00(4.17) 
61,8 
54(4.70) 
370 
9.67(4.56) 
1.51 (2.7-0.3 
P=0.013 
All periods      1.6 (2.5-0.6) 
P=0.002 
Hospital 
Anxiety and 
Depression 
Scale – HADS 
Depression 
Baseline 225 
8.83(4.58) 
87,8 
53(3.83) 
66 
8.65(3.99) 
66 
10.36(5.06) 
444 
8.97(4.46) 
 
6 months 204 
8.43(4.71) 
78 
8.38(5.14) 
56 
7.50(4.57) 
63 
7.57(4.39) 
401 
8.16(4.73) 
1.47 (2.7-0.3) 
P=0.02 
12 
months 
192 
8.41(4.90) 
75 
8.27(5.32) 
57 
7.35(4.85) 
62 
8.10(5.02) 
386 
8.18(4.99) 
0.77 (2.0-(- 0.5)) 
ns 
24 
months 
181 
8.34(5.31) 
75 
8.00(5.44) 
53 
7.77(4.99) 
61 
7.74(5.04) 
370 
8.09(5.23) 
1.43 (2.7-0.2) 
P=0.02 
All periods      1.22 (2.3-0.2) 
P=0.02 
Social 
Functioning 
Questionnair
e (SFQ) 
Baseline 225 
9.49(4.32) 
87,9.09(4.82
) 
66,9.51(4.45
) 
66,9.77(4.92) 444,9.45(4.52
) 
 
6 months 204 
9.28(4.86) 
78,10.02(5.3
0) 
56,8.40(5.59
) 
63,8.35(4.89) 401,9.15(5.07
) 
1.32 (2.5-0.13) 
P=0.03 
12 
months 
192 
9.11(5.06) 
75,9.07(4.94
) 
57,8.97(5.94
) 
62,8.60(4.91) 386,9.00(5.14
) 
0.81 (2.0-(-0.39)) 
ns 
24 
months 
182 
8.69(5.07) 
76,8.51(5.24
) 
53,8.09(5.33
) 
61,8.27(4.70) 372,8.50(5.07
) 
0.76 (2.0-(-0.44)) 
ns 
All periods      0.96 (2.0-(-0.04)) 
P=0.06 
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Table 5: Summary results from linear regression analysis of number of sessions separated 
by therapist group 
 
 95% CI  
Comparison Difference Lower Limit Upper Limit Probability 
Graduates vs Assistant 
psychologists 
-0.97 -2.26 0.32 0.1396 
Nurses vs Assistant 
psychologists 
2.03 0.74 3.32 0.0022 
Nurses vs Graduates  3.00 1.63 4.37 <.0001 
Nurses vs other groups 
combined 
2.52 1.35 3.68 <.0001 
 
 
 
 
 
 
Table 6. Proportions of patients showing significant improvement (HAI≤15) after one year  
 
Therapist 
Group  
Phase in trial  Number of 
patients (%) 
with HAI 
scores ≤15 
Odds ratio of 
improvement 
compared with 
standard care -all 
times (sig) 
95% 
Confidence 
Interval 
Standard care 3 months 31 (14.6)  
 
 
6 months 30 (14.7) 
12 months 42 (21.8) 
24 months 43 (23.5) 
CBT-HA – 
Assistant 
psychologists 
3 months 16 (19.5)   1.58  (P =0.05) 0.99-2.51  
6 months 24 (30.8) 
12 months 19 (25.3) 
24 months 22 (28.9) 
CBT-HA - 
Graduates 
3 months 10(16.9) 2.05 (P =0.005) 1.25-3.36 
6 months 24(42.9) 
12 months 24(42.1) 
24 months 18(34.0) 
CBT-HA - 
Nurses 
3 months 28(43.8) 3.16 (P<0.0001) 1.97-5.06 
6 months 40(63.5) 
12 months 33(53.2) 
24 months 27(44.3) 
 
RESPONSE TO REVIEWER 3 
Reviewer #3: The changes the authors have made to this paper have much improved it and I 
would support it's publication.  The only comment I have is that there is still a suggestion 
that the comparison was with trained "qualified" psychologists in places and this needs to 
be changed.   
 
The changes required are: 
 
1.  What this paper adds - first bullet point - should say perhaps '...significantly superior to 
other naïve therapists including assistant psychologists' 
Response: Change made to ‘What this paper adds’ to include this 
2.  Discussion, first paragraph ...'...the first to suggest superiority of nurses over assistant 
psychologists" 
Response: Done 
 
3.  Discussion, second paragraph, penultimate sentence:  '...rather than an assistant 
psychologist or other naïve therapist' (it said 'other health professional but some weren't - a 
psychology graduate is not a health professional) 
Response: There is no agreement on this – many assistant psychologists would regard 
themselves as integral health professional but we have removed the adjective ‘health’. 4.   
4. Discussion, third paragraph first sentence'... more appropriate than assistant 
psychologists ...' 
Response: Done 
 
5.  Discussion, third paragraph second sentence '... there are now many studies showing 
that trained? psychologists ...' - are these studies you cite with assistant psychologists or 
qualified ones? perhaps specify? 
 
Most of these have used trained psychologists (from our knowledge of the people involved) 
but in many of them there is no mention of training, but ‘most’ has been added as a 
reasonable qualifying adverb.   
*Response to Reviewers
What this paper adds 
 
We already know that nurses are competent at delivering many forms of psychological 
therapy once they have been sufficiently trained. This paper shows that for a specific form 
of therapy, cognitive behaviour therapy adapted for health anxiety given to medical 
patients, the performance of general nurses trained specifically in this treatment, is 
significantly superior to other naïve therapists including assistant psychologists in both the 
short term and over a two year period. Nurses should be the therapists of choice in this 
setting.   
 
 
 
 
*What this paper adds (statement)
